{
    "clinical_study": {
        "@rank": "95935", 
        "arm_group": {
            "arm_group_label": "Low bicarbonate", 
            "arm_group_type": "Experimental", 
            "description": "Low bicarbonate hemodialysis - 30 mEq/L dialysate bicarbonate"
        }, 
        "brief_summary": {
            "textblock": "This study will compare hemodialysis treatment with a standard, high-bicarbonate dialysis\n      bath versus a lower bicarbonate dialysis bath, and will compare intradialytic acid-base\n      changes and overall control of metabolic acidosis with the 2 treatment regimens.   These\n      parameters will be assessed in patients currently receiving high-bicarbonate hemodialysis as\n      part of usual care.  They will then be switched to a lower bicarbonate prescription, after\n      which these parameters will be reassessed.  The study will also examine changes in\n      inflammatory markers, glycemic control, ketogenesis, and lipolysis."
        }, 
        "brief_title": "Comparison of High Versus Low Bicarbonate Hemodialysis", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Kidney Disease", 
            "End-stage Renal Disease", 
            "Metabolic Acidosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acidosis", 
                "Kidney Diseases", 
                "Kidney Failure, Chronic", 
                "Renal Insufficiency, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age >18\n\n          -  Receiving chronic thrice-weekly conventional hemodialysis for at least 6 months\n\n        Exclusion Criteria:\n\n          -  Use of oral alkali within the previous month\n\n          -  Hospitalization within the previous month\n\n          -  Inability to provide written informed consent\n\n          -  Plans for kidney transplant in the next 2 months\n\n          -  Planned change in phosphate binder therapy within the next month\n\n          -  Pregnancy, or planned pregnancy in the next 2 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02098356", 
            "org_study_id": "2012-480"
        }, 
        "intervention": {
            "arm_group_label": "Low bicarbonate", 
            "description": "Low bicarbonate hemodialysis - 30 mEq/L dialysate bicarbonate", 
            "intervention_name": "Low Bicarbonate", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hemodialysis", 
            "dialysis", 
            "acidosis", 
            "bicarbonate"
        ], 
        "lastchanged_date": "March 25, 2014", 
        "location": {
            "contact": {
                "email": "matthew.abramowitz@einstein.yu.edu", 
                "last_name": "Matthew Abramowitz, MD, MS", 
                "phone": "718-430-8566"
            }, 
            "facility": {
                "address": {
                    "city": "Bronx", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10461"
                }, 
                "name": "Albert Einstein College of Medicine"
            }, 
            "investigator": {
                "last_name": "Matthew Abramowitz, MD, MS", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Intradialytic Acid-base Changes and Organic Anion Production With High Versus Low Bicarbonate Hemodialysis", 
        "overall_contact": {
            "email": "matthew.abramowitz@einstein.yu.edu", 
            "last_name": "Matthew Abramowitz, MD, MS", 
            "phone": "7184308566"
        }, 
        "overall_official": {
            "affiliation": "Albert Einstein College of Medicine of Yeshiva University", 
            "last_name": "Matthew Abramowitz, MD, MS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pre-dialysis serum bicarbonate", 
            "safety_issue": "No", 
            "time_frame": "5 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02098356"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Albert Einstein College of Medicine of Yeshiva University", 
            "investigator_full_name": "Matthew Abramowitz", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "serum beta-hydroxybutyrate", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "measure": "beta-hydroxybutyrate clearance", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "measure": "interleukin-6", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "measure": "serum free fatty acids", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "measure": "Time to recover from dialysis", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }, 
            {
                "measure": "Dialysis symptom questionnaire", 
                "safety_issue": "No", 
                "time_frame": "5 weeks"
            }
        ], 
        "source": "Albert Einstein College of Medicine of Yeshiva University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Albert Einstein College of Medicine of Yeshiva University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}